Entering text into the input field will update the search result below

Halozyme announces Phase 2 data on PEGH20 in pancreatic cancer to be presented at ASCO

May 18, 2017 12:40 PM ETHalozyme Therapeutics, Inc. (HALO) StockHALOBy: Douglas W. House, SA News Editor

Recommended For You

More Trending News

About HALO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
HALO--
Halozyme Therapeutics, Inc.